Address: Jl. Let. Jend Suprapto Kav 4
Jakarta 10510
Indonesia
P.O. Box 3105 JAK.
Tel: 6221 – 42873888 – 89
PT Kalbe Farma Tbk is Indonesia’s largest pharmaceutical firm, established in 1966. The company was founded as the Indonesian pharmaceutical industry was born, and has expanded through strategic acquisitions over its 40-year history. Kalbe has expanded into international markets and transformed itself into an integrated consumer health and nutrition enterprise. At the end of 2005 Kalbe was present in seven international markets, namely Malaysia, the Philippines, Thailand, Vietnam, Myanmar, Sri Lanka and South Africa. They company spends more than any other Indonesian pharmaceutical on R&D at $4.5 million and is currently running a stem cell therapeutics lab that is actively developing treatments for burn victims. Kalbe is the largest publicly-listed pharmaceutical company in Southeast Asia with over US$ 1 billion in market capitalization and revenues of over Rp 7 trillion.
The Kalbe Group has an extensive portfolio of brands in ethicals, OTC, energy drinks and nutrition products, as well as a distribution arm that reaches over 1 million outlets. Some of the company’s popular brands are Promag, Mixagrip, Woods, Komix, Prenagen and Extra Joss.
Smit Soni, Kalbe country manager for Malaysia and Singapore, explains the dynamics in the consumer healthcare market in Malaysia, and how Kalbe is ensuring that its products are being adapted…
You have been working at Kalbe for 38 years, and as President Director for 11 years. What has it been like to see the firm transform from a company based…
What role does Indonesia play within Quintiles’ Asian operations? Quintiles has been growing dramatically across the South East Asian Region, which comprises Philippines, Singapore, Thailand, Malaysia, Vietnam and Indonesia as…
Pyridam Farma has achieved and maintained the leading position in terms of growth in the Indonesian pharmaceutical industry for two years. What strategic choices have caused Pyridam to outperform its…
Overall health indicators have improved significantly in Indonesia in recent years. However, the country still faces many challenges and there are many areas in need of further improvement. What is…
Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the…
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being a part of Zuellig…
Many multinational companies have chosen to forgo establishing production facilities in Indonesia or have even shuttered their facilities, as did Janssen-Cilag. With the recent 10/10 decree, it seems the environment…
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
How has the increasing international integration of the Indonesian economy influenced the challenges and transformations the BPOM went through in the past 9 years since its reorganization? The constant changes…
Millennium Pharmacon International has a long history, starting at its founding in 1952. Could you give our readers an overview of the company’s milestones, particularly those from the past decade?…
While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on…
See our Cookie Privacy Policy Here
